Toinv

IMHO Don McCaffrey has made remarkable achievements with this company. The Annual Information Report dated 7/27/15 for fye 4/30/15 states that the company has 22 full-time management, scientific and administration employees. They have to be stretched awfully thin for the amount that's on their plate. Preparing for Phase 3 trial this fall in Europe and China, currently in discussions with several pharmaceutical companies regarding possible partnering and codevelopment arrangements, investigating switching to the Nasdaq, negotiations with the FDA and European authorities, 4 key industry conferences in September alone in London, New York, Stockholm and Toronto, annual general meeting September 30th.....It's no wonder that communication is sparse.

The summary compensation table prepared for the 9/2014 shareholder meeting lists his total compensation as:

• 2012* 2013* 2014
• 937,081* 778,946* 966,435

His unexcercised options are:

• 100,000, 2.44, Expired 6/15
• 286,300, 1.46, Expires 6/16
• 115,600, 1.28, Expires 5/17
• 77,400, 3.27, Expires 5/18

Common shares beneficially owned, controlled or directed by DM at 8/25/14 - 4,320,609

DM is currently earning his pay but there's a pot of gold for him at the end of this rainbow if he can get piggy to market - I'm sure no one wants this more than him.

Chicagoest